Lab test could match brain tumor patients to best drugs
NCT ID NCT06804655
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 38 times
Summary
This study tests a method called pharmacoscopy, where a patient's tumor tissue is analyzed in the lab to find which drugs might work best for them. The goal is to see if this personalized approach is feasible for people with brain tumors that have not responded to standard treatments. About 40 adults with various refractory brain tumors will have their tumor samples tested, and results will guide their next treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cantonal Hospital St Gallen
Sankt Gallen, Canton of St. Gallen, 9007, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Basel
Basel, Basel-Landschaft, 4021, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Zurich
Zurich, Canton of Zurich, 8091, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pharmacoscopy (ex vivo drug profiling of tumor tissue to guide treatment selection)
What this could lead to
If successful, this approach could help doctors choose more effective drugs for individual patients with hard-to-treat brain tumors, potentially improving outcomes.
What could go wrong
This is a small early-phase trial (40 patients) focused on feasibility, not proof of effectiveness. The drug profiling may not always lead to a usable treatment, and benefits are uncertain.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.